Table 2.

Impact of smoking status before LT (active smoker, ex-smoker, or nonsmoker) on clinical events during follow-up. Multinomial regression.

	Group 1: Non-Smokers (n = 59)	Group 2: Ex-Smokers (n = 130)	Group 3: Active Smokers (n = 125)	p
Alcohol Use Relapse	10	25	35	0.13
Substance Use Relapse	1	0	8	0.02
Graft Cirrhosis	10	17	18	0.77
Biopsy-Proven Alcoholic Steatohepatitis	2	2	1	0.52
HCC Recurrence	3	3	6	0.33
Skin Cancer	2	4	3	0.92
Non–Skin Cancer	2	14	18	0.04

HCC = hepatocellular carcinoma.